High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT)-Reference-Cited by-同舟云学术

High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT)

Published:2016-07 Issue:28 Volume:95 Page:e3968
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Li Ru,Zhao Jin-Xia,Su Yin,He Jing,Chen Li-Na,Gu Fei,Zhao Cheng,Deng Xue-Rong,Zhou Wei,Hao Yan-Jie,Xue Yu,Liu Hua-Xiang,Zhao Yi,Zou Qing-Hua,Liu Xiang-Yuan,Zhu Ping,Sun Ling-Yun,Zhang Zhuo-Li,Zou He-Jian,Li Xing-Fu,Liu Yi,Fang Yong-Fei,Keystone Edward,McInnes Iain B.,Li Zhan-Guo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference26 articles.

1. Treating rheumatoid arthritis to target: recommendations of an international task force;Smolen;Ann Rheum Dis,2010

2. Therapies for active rheumatoid arthritis after methotrexate failure;O’Dell;N Engl J Med,2013

3. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial;Goekoop-Ruiterman;Arthritis Rheum,2005

4. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention;Landewé;Arthritis Rheum,2002

5. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial);Verstappen;Ann Rheum Dis,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating PCSK9 relates to aggravated disease activity, Th17/Treg imbalance, and predicts treatment outcome of conventional synthetic DMARDs in rheumatoid arthritis patients;Irish Journal of Medical Science (1971 -);2023-02-24

2. Efficacy of Wushaoshe Qufeng Tablet and leflunomide combination therapy in the management of rheumatoid arthritis, and its influence on incidence of adverse drug reactions;Tropical Journal of Pharmaceutical Research;2022-04-28

3. Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial;Signal Transduction and Targeted Therapy;2022-03-07

4. Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial;Rheumatology International;2021-09-29

5. Pancytopenia after Low-Dose Methotrexate Therapy in Two Hemodialysis Patients with Rheumatoid Arthritis;The American Journal of the Medical Sciences;2021-09